Nuveen Asset Management, LLC Forte Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $43,179 - $62,550	-40,355 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.02 - $3.36 $14,119 - $23,486	-6,990 Reduced 14.76%	40,355 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$2.96 - $36.67 $10,638 - $131,791	3,594 Added 8.21%	47,345 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $1.38 Million - $1.86 Million	43,751 New	43,751 $1.47 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.